GE HealthCare Technologies Inc. with ticker code (GEHC) have now 14 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $105.00 and $86.00 calculating the average target price we see $92.74. Now with the previous closing price of $77.55 this would indicate that there is a potential upside of 19.6%. The day 50 moving average is $81.14 while the 200 day moving average is $77.02. The company has a market capitalization of 35.73B. The stock price is currently at: $78.27 USD
The potential market cap would be $42,725,588,928 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 22.75, revenue per share of $42.80 and a 5.63% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
